Adelaide Research & Scholarship
Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/136741
| Citations | ||
| Scopus | Web of Science® | Altmetric |
|---|---|---|
|
?
|
?
|
|
| Type: | Journal article |
| Title: | Atherosclerotic Cardiovascular Risk With Combination Avelumab and Axitinib |
| Author: | Tan, S. Day, D. Nicholls, S.J. Segelov, E. |
| Citation: | Journal of Clinical Oncology, 2022; 40(29):3467-3469 |
| Publisher: | American Society of Clinical Oncology (ASCO) |
| Issue Date: | 2022 |
| ISSN: | 0732-183X 1527-7755 |
| Statement of Responsibility: | Sean Tan, Daphne Day, Stephen J. Nicholls, Eva Segelov |
| Keywords: | Humans Carcinoma, Renal Cell Kidney Neoplasms Cardiovascular Diseases Risk Factors Antibodies, Monoclonal, Humanized Axitinib Heart Disease Risk Factors |
| Rights: | © 2022 American Society of Clinical Oncology. All rights reserved. |
| DOI: | 10.1200/JCO.22.00712 |
| Grant ID: | NHMRC |
| Published version: | http://dx.doi.org/10.1200/jco.22.00712 |
| Appears in Collections: | Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.